M.S, a 42-year-old Caucasian woman, presents to her primary care physician with complaints of polyuria and excessive thirst for the past four weeks. The patient is 5 feet 5 inches tall and weighs 160 pounds; her calculated BMI is 26.6 kg/m2 (BMI for a normal woman = 18 to 25 kg/m2). She confirms a family history of diabetes on her father’s side and admits to a generally sedentary occupation and lifestyle. Her fasting blood glucose level is 142 mg/dL (normal = 80 to 100 mg/dL). Her physician prescribes an oral hypoglycemic agent but this results in episodes of hypoglycemia with an accompanying weight gain of 10 pounds. Based on this, her physician switches her to Liraglutide (Victoza®) 0.6 mg subcutaneous injection (sub-q) once per day (qd). Questions: What group of oral hypoglycemic agents might have been responsible for the hypoglycemia/weight gain that M.S. initially experienced? What is the mechanism of action of these drugs in treating diabetes? In addition to controlling her diabetes, what beneficial effect would Liraglutide have in M.S.?
[Expert Solution]: M.S, a 42-year-old Caucasian woman,…
Need help with your Endocrine & Metabolic Disorders case study or NCLEX preparation? Connect with a verified Nursing expert now.